Recombinant Antibodies to the Ebola Virus Glycoprotein

Currently, there are no approved therapies for targeted prevention and treatment of Ebola hemorrhagic fever. In the present work, we describe the development of a eukaryotic expression system for the production of three full-length chimeric antibodies (IgG1-kappa isotypes) GPE118, GPE325, and GPE534...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Acta Naturae
Main Authors: Panina, A. A., Dementieva, I. G., Aliev, T. K., Toporova, V. A., Balabashin, D. S., Bokov, M. N., Pozdnyakova, L. P., Shchemchukova, O. B., Dolgikh, D. A., Sveshnikov, P. G., Kirpichnikov, M. P.
Formato: Artigo
Idioma:Inglês
Publicado: A.I. Gordeyev 2017
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5762832/
https://ncbi.nlm.nih.gov/pubmed/29340221
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares